These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 30097698)

  • 41. A role for the serotonin reuptake transporter in the brain and intestinal features of autism spectrum disorders and developmental antidepressant exposure.
    Margolis KG
    J Chem Neuroanat; 2017 Oct; 83-84():36-40. PubMed ID: 28213183
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lamotrigine augmentation of serotonin re-uptake inhibitors in obsessive-compulsive disorder.
    Kumar TC; Khanna S
    Aust N Z J Psychiatry; 2000 Jun; 34(3):527-8. PubMed ID: 10881981
    [No Abstract]   [Full Text] [Related]  

  • 43. Revisiting serotonin reuptake inhibitors and the therapeutic potential of "uptake-2" in psychiatric disorders.
    Daws LC; Koek W; Mitchell NC
    ACS Chem Neurosci; 2013 Jan; 4(1):16-21. PubMed ID: 23336039
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serotonin transporter occupancy and the functional neuroanatomic effects of citalopram in geriatric depression.
    Smith GS; Kahn A; Sacher J; Rusjan P; van Eimeren T; Flint A; Wilson AA
    Am J Geriatr Psychiatry; 2011 Dec; 19(12):1016-25. PubMed ID: 21841458
    [TBL] [Abstract][Full Text] [Related]  

  • 45. SSRIs target prefrontal to raphe circuits during development modulating synaptic connectivity and emotional behavior.
    Soiza-Reilly M; Meye FJ; Olusakin J; Telley L; Petit E; Chen X; Mameli M; Jabaudon D; Sze JY; Gaspar P
    Mol Psychiatry; 2019 May; 24(5):726-745. PubMed ID: 30279456
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serotonergic drugs for depression and beyond.
    Stahl SM; Lee-Zimmerman C; Cartwright S; Morrissette DA
    Curr Drug Targets; 2013 May; 14(5):578-85. PubMed ID: 23531115
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Associating in vitro target binding and in vivo CNS occupancy of serotonin reuptake inhibitors in rats: the role of free drug concentrations.
    Bundgaard C; Sveigaard C; Brennum LT; Stensbøl TB
    Xenobiotica; 2012 Mar; 42(3):256-65. PubMed ID: 22017605
    [TBL] [Abstract][Full Text] [Related]  

  • 48. PET measurement of serotonin transporter occupancy: a comparison of escitalopram and citalopram.
    Lundberg J; Christophersen JS; Petersen KB; Loft H; Halldin C; Farde L
    Int J Neuropsychopharmacol; 2007 Dec; 10(6):777-85. PubMed ID: 17201996
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recent developments in the design of anti-depressive therapies: targeting the serotonin transporter.
    Butler SG; Meegan MJ
    Curr Med Chem; 2008; 15(17):1737-61. PubMed ID: 18673223
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serotonin transporter gene promoter polymorphisms modify the association between paroxetine serotonin transporter occupancy and clinical response in major depressive disorder.
    Ruhé HG; Ooteman W; Booij J; Michel MC; Moeton M; Baas F; Schene AH
    Pharmacogenet Genomics; 2009 Jan; 19(1):67-76. PubMed ID: 18987562
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mice lacking the serotonin 5-HT2B receptor as an animal model of resistance to selective serotonin reuptake inhibitors antidepressants.
    Diaz SL; Narboux-Nême N; Boutourlinsky K; Doly S; Maroteaux L
    Eur Neuropsychopharmacol; 2016 Feb; 26(2):265-279. PubMed ID: 26727039
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Occupancy of brain serotonin transporters during treatment with paroxetine in patients with social phobia: a positron emission tomography study with 11C McN 5652.
    Kent JM; Coplan JD; Lombardo I; Hwang DR; Huang Y; Mawlawi O; Van Heertum RL; Slifstein M; Abi-Dargham A; Gorman JM; Laruelle M
    Psychopharmacology (Berl); 2002 Dec; 164(4):341-8. PubMed ID: 12457263
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding.
    Sánchez C; Hyttel J
    Cell Mol Neurobiol; 1999 Aug; 19(4):467-89. PubMed ID: 10379421
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A dose-finding study of duloxetine based on serotonin transporter occupancy.
    Takano A; Suzuki K; Kosaka J; Ota M; Nozaki S; Ikoma Y; Tanada S; Suhara T
    Psychopharmacology (Berl); 2006 Apr; 185(3):395-9. PubMed ID: 16506079
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Conformationally restricted homotryptamines 3. Indole tetrahydropyridines and cyclohexenylamines as selective serotonin reuptake inhibitors.
    Deskus JA; Epperson JR; Sloan CP; Cipollina JA; Dextraze P; Qian-Cutrone J; Gao Q; Ma B; Beno BR; Mattson GK; Molski TF; Krause RG; Taber MT; Lodge NJ; Mattson RJ
    Bioorg Med Chem Lett; 2007 Jun; 17(11):3099-104. PubMed ID: 17391962
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Utility of organotypic raphe slice cultures to investigate the effects of sustained exposure to selective 5-HT reuptake inhibitors on 5-HT release.
    Nagayasu K; Yatani Y; Kitaichi M; Kitagawa Y; Shirakawa H; Nakagawa T; Kaneko S
    Br J Pharmacol; 2010 Dec; 161(7):1527-41. PubMed ID: 20698856
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genotyping of patients treated with selective serotonin reuptake inhibitors.
    Solhaug V; Haslemo T; Kringen MK; Molden E; Dietrichs ES
    Tidsskr Nor Laegeforen; 2022 Sep; 142(13):. PubMed ID: 36164782
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serotonin transporter occupancy by the SSRI citalopram predicts default-mode network connectivity.
    Schrantee A; Lucassen PJ; Booij J; Reneman L
    Eur Neuropsychopharmacol; 2018 Oct; 28(10):1173-1179. PubMed ID: 30082141
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antenatal depression and antidepressants during pregnancy: unraveling the complex interactions for the offspring.
    Olivier JD; Åkerud H; Sundström Poromaa I
    Eur J Pharmacol; 2015 Apr; 753():257-62. PubMed ID: 25094036
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Persistent pulmonary hypertension of the newborn and selective serotonin reuptake inhibitors: lessons from clinical and translational studies.
    Occhiogrosso M; Omran SS; Altemus M
    Am J Psychiatry; 2012 Feb; 169(2):134-40. PubMed ID: 22420034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.